NCT00460538

Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Milsing d.o.o. · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to determine weather Lectranal is effective in treatment of seasonal allergic rhinitis symptoms.

Detailed description

Patients allergic to the specific pollen are divided into two groups randomly. One group is being administered Lectranal and the other group is being administered placebo during the period of 6 weeks in season of the pollen. Methods used for evaluation are: SARS questionnaire(seasonal allergic rhinitis symptoms), Mini RQLQ (mini rhinoconjunctivitis quality of life questionnaire) skin Prick test, specific IgE and IgG, eosinophilia in nasal secretion. Methods used for follow up safety include side effects report, physical examination and vital signs.

Conditions

• Seasonal Allergic Rhinitis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Lectranal	Dosage form: capsule 1: Dosage: 2 capsule Frequency and duration: 2 times daily over the 6 weeks
DIETARY_SUPPLEMENT	placebo	Dosage form: capsule 2: Dosage: 2 capsules Frequency and duration: 2 times daily over the 6 weeks

Timeline

• Start date: 2007-04-01
• Primary completion: 2007-10-01
• Completion: 2007-11-01
• First posted: 2007-04-16
• Last updated: 2010-04-05

Locations

1 site across 1 country: Croatia